Somewhat quietly, in state-of-the-art molecular facilities at the world-renowned University of Texas MD Anderson Cancer Center, is almost secret research on the power of nutrition to kill cancer and help traditional cancer therapies work better. After all, the MD Anderson Cancer Center is at the forefront of new-fangled biological cancer medicines and has been a bastion of support for the rather toxic cancer treatments that have dominated Western medicine for decades. On April 21, 2011 they published a groundbreaking scientific review of their research on their favorite anti-cancer nutrient – curcumin. Times are a changing.
Their fascination with nutrition is born out of the fact that various nutrients seem to possess intelligence – meaning they can actually tell the difference between a healthy cell and a cancer cell. They are actively researching curcumin, tocotrienols, green tea, quercetin, Resveratrol Natural phenol or type of antioxidant found in red grapes, red wine. Research has shown beneficial effects as anti-cancer and anti-inflammatory agents along with supporting healthy blood sugar and cardiovasculature function., and many other natural substances. In the case of cancer cells, these nutrients help unleash a powerful response designed to kill the cancer. In the case of healthy cells, the nutrients promote survival and increase the ability of cells to tolerate stress. No current drugs have the ability to do this, even the newer biological medicines that are more like a gene shotgun.
Read the Full Article here: http://www.wellnessresources.com/health/articles/curcumin_helps_change_gene_function_to_combat_cancer/
We Lost the War on Cancer – Review of Alternative Cancer Therapies
We have lost the war on cancer. At the beginning of the last century, one person in twenty would get cancer. In the 1940s it was one out of every sixteen people. In the 1970s it was one person out of ten. Today one person out of three gets cancer in the course of their life.
The cancer industry is probably the most prosperous business in the United States. In 2014, there will be an estimated 1,665,540 new cancer cases diagnosed and 585,720 cancer deaths in the US. $6 billion of tax-payer funds are cycled through various federal agencies for cancer research, such as the National Cancer Institute (NCI). The NCI states that the medical costs of cancer care are $125 billion, with a projected 39 percent increase to $173 billion by 2020.
The simple fact is that the cancer industry employs too many people and produces too much income to allow a cure to be found. All of the current research on cancer drugs is based on the premise that the cancer market will grow, not shrink.
John Thomas explains to us why the current cancer industry prospers while treating cancer, but cannot afford to cure it in Part I. In Part II, he surveys the various alternative cancer therapies that have been proven effective, but that are not approved by the FDA.